Related Experiment Video
Updated: Jul 6, 2026

09:51
Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
Published on: February 2, 2016
Improved genetic manipulation of human embryonic stem cells
Stefan R Braam1, Chris Denning, Stieneke van den Brink
1Hubrecht Institute, Developmental Biology and Stem Cell Research, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Nature Methods
|April 9, 2008
Summary
Optimizing gene transfer in human embryonic stem cells (hESCs) is crucial for genetic manipulation. This study developed efficient transfection protocols that maintain pluripotency and differentiation potential in hESCs.
Area of Science:
- Stem cell biology
- Genetic engineering
- Molecular biology
Background:
- Transfection efficiency is a major limitation for genetic manipulation of human embryonic stem cells (hESCs).
- Variations in hESC derivation and culture necessitate tailored transfection protocols.
Purpose of the Study:
- To optimize transfection protocols for efficient gene transfer in multiple hESC lines.
- To ensure genetic manipulation does not compromise hESC pluripotency or differentiation capacity.
Main Methods:
- Standardized feeder-free culture conditions were established for diverse hESC lines.
- Transient transfection methods were optimized for clonal growth and gene delivery.
- Pluripotency, differentiation potential, and karyotype stability were assessed post-transfection.
Main Results:
- Optimized protocols enabled efficient gene transfer across multiple hESC lines with varying growth needs.
- Transfection did not result in loss of pluripotency.
- Stably transfected hESC lines retained their differentiation potential.
- Most resulting cell lines exhibited normal karyotypes.
Conclusions:
- Efficient and reliable gene transfer methods have been established for hESCs.
- These optimized protocols support genetic manipulation while preserving critical stem cell characteristics.
- The findings facilitate further research and therapeutic applications using genetically modified hESCs.
Related Concept Videos
Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
What is Genetic Engineering?
Overview

